Literature DB >> 32813825

Cardiovascular Imaging and Interventional Procedures in Patients with Novel Coronavirus Infection.

Isabela Bispo Santos da Silva Costa1, Carlos Eduardo Rochitte2, Carlos M Campos2, Silvio Henrique Barberato3, Gláucia Maria Moraes de Oliveira4, Marcelo Antônio Cartaxo Queiroga Lopes5, Cesar Higa Nomura2, Alexandre A Abizaid2, Giovanni Cerri2, Roberto Kalil Filho2, Ludhmila Abrahão Hajjar1.   

Abstract

The coronavirus disease 2019 (COVID-19) pandemic is a huge challenge to the health system because of the exponential increase in the number of individuals affected. The rational use of resources and correct and judicious indication for imaging exams and interventional procedures are necessary, prioritizing patient, healthcare personnel, and environmental safety. This review was aimed at guiding health professionals in safely and effectively performing imaging exams and interventional procedures.

Entities:  

Mesh：

Year:  2020        PMID： 32813825     DOI： 10.36660/abc.20200370

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN： 0066-782X            Impact factor:   2.000


  2 in total

1.  Echocardiographic Findings in Patients with COVID-19 with and without Previous Cardiovascular Disease.

Authors:  Silvio Henrique Barberato; Rafael Borsoi; Fabio Roston; Hudson Laerte Machado Miranda; Pedro Patriota; Maria Estefania Otto; Adenalva Lima de Souza Beck; Anderson da Costa Armstrong; João Marcos Bemfica Barbosa Ferreira; Ana Cristina Camarozano; Letícia Braga Paciello da Silva; Marcos Valério Coimbra Resende; Marcelo Luiz Campos Vieira; Miguel Morita Fernandes-Silva
Journal:  Arq Bras Cardiol       Date:  2021-12       Impact factor: 2.667

2.  Abnormal Echocardiographic Findings in Hospitalized Patients with Covid-19: A Systematic Review and Meta-analysis.

Authors:  Silvio Henrique Barberato; Eduardo G Bruneto; Gabriel S Reis; Paula Rauen Franco de Oliveira; Alexandre F Possamai; Odilson Silvestre; Miguel M Fernandes Silva
Journal:  Arq Bras Cardiol       Date:  2022-08       Impact factor: 2.667
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.